Qilai Long

1.3k total citations
34 papers, 798 citations indexed

About

Qilai Long is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Qilai Long has authored 34 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 23 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Qilai Long's work include Renal cell carcinoma treatment (20 papers), Renal and related cancers (15 papers) and Epigenetics and DNA Methylation (6 papers). Qilai Long is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Renal and related cancers (15 papers) and Epigenetics and DNA Methylation (6 papers). Qilai Long collaborates with scholars based in China, United States and United Kingdom. Qilai Long's co-authors include Jianming Guo, Li Liu, Jiejie Xu, Yu Xia, Qi Bai, Wei Xi, Hang Wang, Qixia Xu, Da Fu and Yu Sun and has published in prestigious journals such as Nature Communications, PLoS ONE and Oncogene.

In The Last Decade

Qilai Long

33 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qilai Long China 16 422 248 169 169 150 34 798
Susan E. Alters United States 14 443 1.0× 184 0.7× 339 2.0× 233 1.4× 170 1.1× 32 1.1k
Shuwei Chen China 20 426 1.0× 111 0.4× 126 0.7× 216 1.3× 202 1.3× 51 871
Yonglong Zou United States 11 658 1.6× 107 0.4× 105 0.6× 105 0.6× 250 1.7× 16 1.2k
Jon Smythe United Kingdom 15 329 0.8× 89 0.4× 81 0.5× 133 0.8× 178 1.2× 25 752
Patrycja Pawlikowska France 15 391 0.9× 59 0.2× 61 0.4× 137 0.8× 177 1.2× 24 682
Gualtiero Mariani Italy 14 497 1.2× 46 0.2× 229 1.4× 114 0.7× 270 1.8× 18 927
Qijia Xuan China 18 325 0.8× 161 0.6× 223 1.3× 241 1.4× 511 3.4× 30 922
Eric G. Wright United Kingdom 10 254 0.6× 169 0.7× 105 0.6× 137 0.8× 231 1.5× 13 671
Erandi Rajagurubandara United States 11 265 0.6× 131 0.5× 95 0.6× 239 1.4× 289 1.9× 12 787
Vanessa T. Garrido United States 16 296 0.7× 61 0.2× 198 1.2× 181 1.1× 294 2.0× 26 697

Countries citing papers authored by Qilai Long

Since Specialization
Citations

This map shows the geographic impact of Qilai Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qilai Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qilai Long more than expected).

Fields of papers citing papers by Qilai Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qilai Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qilai Long. The network helps show where Qilai Long may publish in the future.

Co-authorship network of co-authors of Qilai Long

This figure shows the co-authorship network connecting the top 25 collaborators of Qilai Long. A scholar is included among the top collaborators of Qilai Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qilai Long. Qilai Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dou, Xuefeng, Qiang Fu, Qilai Long, et al.. (2023). PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. Nature Metabolism. 5(11). 1887–1910. 88 indexed citations
2.
Long, Qilai, Qiang Fu, Qixia Xu, et al.. (2022). Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance. Oncogene. 41(45). 4941–4959. 20 indexed citations
3.
Long, Qilai, Ai-Hong Ma, Hongyong Zhang, et al.. (2020). Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer. Cancer Immunology Immunotherapy. 69(11). 2305–2317. 12 indexed citations
4.
Lin, Tzu‐yin, Yanjun Zhu, Yuanpei Li, et al.. (2019). Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia. Nanomedicine Nanotechnology Biology and Medicine. 20. 102004–102004. 18 indexed citations
5.
6.
Liu, Li, Yu Xia, Jiajun Wang, et al.. (2018). A preliminary study on classification and therapeutic strategies for spontaneous perirenal hemorrhage. International Journal of Surgery. 54(Pt A). 86–91. 6 indexed citations
7.
Chen, Fei, Qilai Long, Da Fu, et al.. (2018). Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance. Nature Communications. 9(1). 4315–4315. 85 indexed citations
8.
Long, Qilai, Tzu‐yin Lin, Yee Huang, et al.. (2018). Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model. Nanomedicine Nanotechnology Biology and Medicine. 14(3). 789–799. 28 indexed citations
9.
Wang, Jiajun, Li Liu, Yang Qu, et al.. (2017). HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients. Cancer Immunology Immunotherapy. 67(1). 79–87. 5 indexed citations
10.
Wang, Jiajun, Li Liu, Qilai Long, et al.. (2017). Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma. Oncology Letters. 14(2). 1550–1560. 7 indexed citations
11.
Xia, Yu, Li Liu, Qi Bai, et al.. (2016). Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma. Scientific Reports. 6(1). 32657–32657. 16 indexed citations
12.
Xi, Wei, Li Liu, Jiajun Wang, et al.. (2016). High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma. Scientific Reports. 6(1). 29177–29177. 18 indexed citations
13.
Wang, Hang, Qilai Long, Yiwei Wang, et al.. (2016). Tuberous sclerosis complex-associated renal angiomyolipomas: A single center study of 17 consecutive cases. Oncology Letters. 12(2). 1501–1506. 2 indexed citations
14.
Lin, Tzu‐yin, Wenchang Guo, Qilai Long, et al.. (2016). HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy. Theranostics. 6(9). 1324–1335. 70 indexed citations
15.
Wang, Jiajun, Li Liu, Wei Xi, et al.. (2016). Prognostic value of UTX expression in patients with clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 34(8). 338.e19–338.e27. 13 indexed citations
16.
Long, Qilai, Li Liu, Yu Xia, et al.. (2015). High peritumoral Bmi-1 expression is an independent prognosticator of poor prognosis in renal cell carcinoma. Tumor Biology. 36(10). 8007–8014. 4 indexed citations
17.
Xia, Yu, Li Liu, Qilai Long, et al.. (2015). Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 34(1). 5.e1–5.e9. 8 indexed citations
18.
Wang, Hang, Lin Zhou, Jianming Guo, et al.. (2014). Mini-Flank Supra-12th Rib Incision for Open Partial Nephrectomy Compared with Laparoscopic Partial Nephrectomy and Traditional Open Partial Nephrectomy. PLoS ONE. 9(2). e89155–e89155. 11 indexed citations
19.
Long, Qilai, Jianming Guo, Yuanfeng Yang, et al.. (2013). Experience of Mini-Percutaneous Nephrolithotomy in the Treatment of Large Impacted Proximal Ureteral Stones. Urologia Internationalis. 90(4). 384–388. 24 indexed citations
20.
Liu, Li, Lei Zhong, Hang Wang, et al.. (2013). Prognostic Value of EZH2 Expression and Activity in Renal Cell Carcinoma: A Prospective Study. PLoS ONE. 8(11). e81484–e81484. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan E. Alters Breakdown of academic impact, for papers by Shuwei Chen Breakdown of academic impact, for papers by Yonglong Zou Breakdown of academic impact, for papers by Jon Smythe Breakdown of academic impact, for papers by Patrycja Pawlikowska Breakdown of academic impact, for papers by Gualtiero Mariani Breakdown of academic impact, for papers by Qijia Xuan Breakdown of academic impact, for papers by Eric G. Wright Breakdown of academic impact, for papers by Erandi Rajagurubandara Breakdown of academic impact, for papers by Vanessa T. Garrido
Rankless by CCL
2026